Using nominal group technique among clinical providers to identify barriers and prioritize solutions to scaling up opioid agonist therapies in Ukraine

Int J Drug Policy. 2017 Nov;49:48-53. doi: 10.1016/j.drugpo.2017.07.025. Epub 2017 Sep 26.


Background: Opioid agonist therapies (OAT) like methadone and buprenorphine maintenance treatment remain markedly under-scaled in Ukraine despite adequate funding. Clinicians and administrators were assembled as part of an implementation science strategy to scale-up OAT using the Network for Improvement of Addiction Treatment (NIATx) approach.

Methods: Nominal Group Technique (NGT), a key ingredient of the NIATx toolkit, was directed by three trained coaches within a learning collaborative of 18 OAT clinicians and administrators to identify barriers to increase OAT capacity at the regional "oblast" level, develop solutions, and prioritize local change projects. NGT findings were supplemented from detailed notes collected during the NGT discussion.

Results: The top three identified barriers included: (1) Strict regulations and inflexible policies dictating distribution and dispensing of OAT; (2) No systematic approach to assessing OAT needs on regional or local level; and (3) Limited funding and financing mechanisms combined with a lack of local/regional control over funding for OAT treatment services.

Conclusions: NGT provides a rapid strategy for individuals at multiple levels to work collaboratively to identify and address structural barriers to OAT scale-up. This technique creates a transparent process to address and prioritize complex issues. Targeting these priorities allowed leaders at the regional and national level to advocate collectively for approaches to minimize obstacles and create policies to improve OAT services.

Keywords: Buprenorphine; Implementation science; Methadone; NIATx; Nominal group technique; Opioid agonist treatment (OAT); People who inject drugs (PWID); Structural barriers; Ukraine.

MeSH terms

  • Budgets
  • Buprenorphine / therapeutic use
  • Drug Users
  • HIV Infections / prevention & control
  • Health Policy / economics
  • Health Policy / legislation & jurisprudence*
  • Health Policy / trends
  • Humans
  • Methadone / therapeutic use
  • Narcotics / agonists*
  • Opiate Substitution Treatment / economics
  • Opiate Substitution Treatment / trends*
  • Opioid-Related Disorders / rehabilitation
  • Substance Abuse, Intravenous / prevention & control
  • Ukraine


  • Narcotics
  • Buprenorphine
  • Methadone